Coronavirus Update: What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out

by | Aug 21, 2022 | Stock Market

Get ready for a big change in how the U.S. will pay for COVID-19 vaccines and treatments.  The Department of Health and Human Services is expected to hold a meeting later this month with drug makers, pharmacies, and state health departments to discuss moving coverage of pandemic therapies away from the U.S. government and into a commercial market, according to The Wall Street Journal. 

Arpa Garay, Moderna’s
chief commercial officer, told investors on a recent earnings call that the company is already preparing for the evolution of the COVID-19 vaccine market. “We are prepared for a shift to the commercial market in the U.S. for COVID boosters, where the market will be more fragmented than it was during the pandemic, where the U.S. government was the sole purchaser of vaccines,” she said. Pfizer
told investors last month that putting its COVID-19 products into a commercial market frees up the company to broaden its distribution channels and run brand campaigns. “All of these are things that actually Pfizer does and the commercial organization of Pfizer does really well. This is our sweet spot,” Angela Hwang, Pfizer’s group president of biopharmaceuticals, said in July during an earnings call. “We look forward to building on top of what the government has been doing, which has been really excellent, and building on top of that to do more and to support greater initiatives across the country.” One major complication to changing how COVID-19 vaccines and treatments are paid for is figuring out how to ensure that they’re still available to the 30 million people in the U.S. who do not have health insurance. Another issue is that Medicare and Medicare don’t pay for therapies that are available due to emergency authorizations. While the COVID-19 shots developed by BioNTech
/Pfizer and Moderna are now fully approved, Merck
and Pfizer’s antivirals are not …

Article Attribution | Read More at Article Source

Share This